White House mandates 30-day pre-release review for frontier AI

The White House has issued formal implementation guidance under Executive Order 14409, introducing a mandatory 30-day federal review window for frontier artificial intelligence models prior to public deployment.

The guidance establishes a uniform pre-release notification standard for commercial developers whose models exceed designated compute and capability baselines. Under the new protocol, developers must submit comprehensive technical dossiers to federal authorities before granting general API access or publishing model weights. The filing initiates an administrative review period intended to verify model mitigations against biological, chemical, and cyber hazards.

Federal scrutiny focuses heavily on computational biology and chemistry pipelines. The technical annex to the guidance specifies rigorous screening measures for models trained on functional genomics, pathogen transmission dynamics, and protein-structure design. Developers must demonstrate that dual-use foundation systems cannot assist non-expert users in synthesising regulated pathogens or circumventing established laboratory biosecurity screens. Where a system demonstrates autonomous design capabilities for high-consequence agents, the evaluation window empowers federal examiners to inspect model checkpoints directly.

To manage pre-deployment testing, the guidance introduces a structured three-tier partner framework. Tier 1 encompasses certified national laboratories and accredited academic consortia. These institutions will receive early, secure access to red-team models for systemic CBRN risks and structural safety anomalies during training runs and post-training refinement.

Tier 2 covers commercial enterprise partners operating within audited compute enclaves. These entities may evaluate model utility under restricted data-sharing agreements, provided they log and share prompt-response interactions with federal oversight bodies. Tier 3 governs standard commercial deployment, which remains prohibited until developers secure administrative sign-off or the statutory 30-day statutory window expires without an injunction.

The regulatory mechanisms impose new governance burdens on frontier labs. Filing packages must include raw red-teaming evaluations, safety benchmark results across standardised biological threat vectors, and full disclosure of post-training interventions such as reinforcement learning from human feedback and representation editing. If examiners find residual capability for autonomous biological protocol generation, federal authorities may extend the evaluation period or request targeted weight-space ablations.

Legal analyses note that the rules bridge voluntary commitments and statutory compliance regimes. By rooting evaluation requirements in federal procurement authority and emergency economic powers, the executive branch bypasses the current legislative deadlock in Congress. Companies failing to submit timely technical dossiers risk administrative sanctions, exclusion from federal cloud computing contracts, and immediate enforcement actions under existing export control and dual-use statutes.

Pharmaceutical and biotechnology enterprises using proprietary foundation models face distinct operational adjustments. While models designed strictly for internal therapeutic discovery remain exempt from full federal disclosure, any general-purpose architecture capable of zero-shot biological design falls under the purview of Executive Order 14409. Cross-disciplinary platforms that blend natural language processing with molecular generation are explicitly covered under the updated computational thresholds.

Industry compliance teams are now assessing the resources required to support federal technical inspections. Independent model audit bodies report that completing standard evaluation batteries within the 30-day window will require synchronised test beds between private labs and government evaluation units. How rapidly federal scientific panels can parse increasingly complex multimodal architectures without stalling commercial release cadences remains to be seen.